title: Trilineage response to recombinant human granulocyte colony-stimulating factor administration in a patient with myelodysplastic syndrome.
authors.forename: C
authors.initials: C
authors.lastname: Rey
authors.forename: B
authors.initials: B
authors.lastname: Bader-Meunier
authors.forename: G
authors.initials: G
authors.lastname: Tertian
authors.forename: F
authors.initials: F
authors.lastname: Mielot
authors.forename: G
authors.initials: G
authors.lastname: Tchernia
authors.forename: A
authors.initials: A
authors.lastname: Yver
mesh_terms: D000293:Adolescent; D016913:Blood Component Transfusion; D005500:Follow-Up Studies; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006454:Hemoglobins / Q000378:metabolism*; D006801:Humans; D007958:Leukocyte Count / Q000187:drug effects*; D008297:Male; D009190:Myelodysplastic Syndromes / Q000097:blood* / Q000188:drug therapy* / Q000628:therapy; D009504:Neutrophils / Q000187:drug effects; D010976:Platelet Count / Q000187:drug effects*; D011994:Recombinant Proteins / Q000627:therapeutic use; D013997:Time Factors
chemical_list: D006454:Hemoglobins; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor